YKYou Jin Kim

You Jin Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


You Jin Kim has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Heon Jong Yoo

    Department of Obstetrics & Gynecology, Chungnam National University Sejong Hospital, Sejong, Korea

    4 shared publications
  • Mina Lee

    Department of Obstetrics & Gynecology, Chungnam National University School of Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 35015, Republic of Korea

    4 shared publications
  • Byung Hun Kang

    Department of Obstetrics & Gynecology, Chungnam National University School of Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 35015, Republic of Korea

    3 shared publications
  • Mia Park

    Department of Obstetrics & Gynecology, Chungnam National University School of Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 35015, Republic of Korea

    3 shared publications
  • Soo Youn Song

    Department of Obstetrics and Gynecology, Chungnam National University Sejong Hospital, 20 Bodeum 7-ro, Sejong 30099, Republic of Korea

    3 shared publications
  • Wonkyo Shin

    Department of Obstetrics and Gynecology, Chungnam National University Sejong Hospital, 20 Bodeum 7-ro, Sejong 30099, Republic of Korea

    3 shared publications

Latest Publications

  • Open Access

    Impact of Contrast-Enhanced Computed Tomography on the Management of Postpartum Hemorrhage with Extravasation

    by Suk Hwan Hyun, Byung Hun Kang, Hae Ri Kim, Ye Won Jung, Won Kyo Shin, Soo Youn Song, Jae Sung Choi, Young Bok Ko, Mina Lee, Mia Park, et al.

    Background: This study aimed to investigate the association of contrast extravasation (EV) detected on contrast-enhanced computed tomography (CE-CT) with the clinical characteristics, management, and outcomes of patients with postpartum hemorrhage (PPH). Methods: We retrospectively analyzed 51 patients with PPH who underwent CE-CT between August 2013 and July 2024. Patients were classified into EV (−) group (n = 28) and EV (+) group (n = 23). Baseline characteristics, management strategies, and clinical outcomes were compared. Results: The proportion of patients with a shock index (SI) ≥ 1.0 was significantly higher in the EV (+) group (10.7% vs. 39.1%, p = 0.017). Surgical intervention was more frequently required in the EV (+) group (10.7% vs. 56.5%, p = 0.001), whereas conservative management alone was more frequently successful in the EV (−) group (89.3% vs. 43.5%, p = 0.001). The EV (+) group showed higher rates of massive blood loss (> 2000 mL, 3.6% vs. 34.8%, p = 0.009), longer hospital stays (4.61 ± 2.61 vs. 6.88 ± 3.78 days, p = 0.034), and more frequent intensive care unit (ICU) admission (10.7% vs. 34.8%, p = 0.039). Patients in the EV (+) group had higher transfusion requirements (p < 0.005) and increased rates of disseminated intravascular coagulation (7.1% vs. 30.4%, p = 0.032). Conclusions: The presence of EV on CE-CT in PPH was associated with more severe clinical features, including greater transfusion requirements, increased rates of surgical intervention, ICU admission, and disseminated intravascular coagulation (DIC). Additionally, a higher proportion of patients with EV had a shock index ≥ 1.0, indicating early hemodynamic compromise.

  • Open Access

    Comparison of Surgical Outcomes Between Single-Port Access Laparoscopic and Single-Site Robotic Surgery in Benign Gynecologic Diseases: A Single-Center Cohort Study

    by Suk Hwan Hyun, Ji Geun Yoo, Ye Won Jung, Won Kyo Shin, Soo Youn Song, Jae Sung Choi, Young Bok Ko, Mina Lee, Byung Hun Kang, Mia Park, et al.

    Background/Objectives: To compare the outcomes of single-port access laparoscopic surgery (SPALS) and single-site robotic surgery (SSRS) for benign gynecological diseases, we retrospectively analyzed clinical data from 367 patients who underwent gynecologic surgery at Sejong Chungnam National University Hospital from October 2020 to December 2023. Methods: Of these 367 patients, 197 underwent SPALS, whereas 170 underwent SSRS. The SPALS group comprised 87 patients who underwent hysterectomy; 107, adnexal surgery (cystectomy: 44, adnexectomy: 63); and 1 myomectomy. The SSRS group included 68 patients who underwent myomectomy; 61, adnexal surgery (cystectomy: 52, adnexectomy: 9); 35, hysterectomy, and 4, sacrocolpopexy. Results: Both surgical techniques were successful, with no patients requiring open surgery. No significant differences were observed in the baseline characteristics between the two groups. Compared with the SPALS group, the SSRS group had a younger age (39.8 ± 9.5 vs. 44.5 ± 12.3 years, p = 0.001). Severe intra-abdominal adhesions were more frequently observed in the SSRS group (p = 0.004). Operation time (118.1 ± 65.9 vs. 57.1 ± 27.3 min, p = 0.001), gas passing time (39.4 ± 15.37 vs. 30.4 ± 13.5 h, p = 0.001), and hospital length of stay (4.26 ± 1.02 vs. 4.02 ± 0.8 days, p = 0.012) were significantly longer in the SSRS group. However, no significant differences were found between the two groups in terms of intraoperative blood loss, intraoperative complications, or readmission rates. Conclusions: SSRS offers a feasible and promising approach for treating gynecological benign diseases. Younger and lower-parity patients tend to undergo SSRS rather than SPALS, with SSRS primarily performed for myomectomy and complex adnexal surgery. However, operation time and gas passing time were significantly longer in the SSRS group.


  • Open Access

    Comparison of Surgical Outcomes Between Single-Port Assess Laparoscopic and Single-Site Robotic Surgery in Benign Gynecologic Diseases: A Single-Center Cohort Study

    by Suk Hwan Hyun, Ji Geun Yoo, Ye Won Jung, Won Kyo Shin, Soo Youn Song, Jae Sung Choi, Young Bok Ko, Mina Lee, Byung Hun Kang, Mia Park, et al.

    Background/Objectives: To compare the outcomes of single-port assessment laparoscopic surgery (SPALS) and single-site robotic surgery (SSRS) for benign gynecological diseases. Methods: The clinical data of 367 patients who underwent gynecologic surgery at Sejong Chungnam National University Hospital from October 2020 to December 2023 were analyzed retrospectively. Of these 367 patients, 197 received SPALS while 170 underwent SSRS. The SPALS group comprise 87 hysterectomies, 107 adnexal surgeries (44 cystectomies, 63 adnexectomies) and 1 myomectomy. The SSRS group includes 68 myomectomies, 61 adnexal surgeries (52 cystectomies, 9 adnexectomies), 35 hysterectomies, and 4 sacrocolpopexies. Results: The results showed that both surgical techniques were successful, and no patients underwent open surgery. There were no significant differences in the baseline characteristics between the two groups. Compared with the SPALS group, the SSRS group had younger age (39.8±9.5 vs 44.5±12.3 years, p = 0.001). Severe intra-abdominal adhesions were more frequently observed in the SSRS group (p = 0.004). Operation time (118.1±65.9 vs 57.1±27.3 min, p = 0.001) and gas passing time (39.4±15.37 vs 30.4±13.5 hours, p = 0.001) were found to be longer, along with more hospital days (4.26±1.02 vs 4.02±0.8 days, p = 0.012), in SSRS group. However, there were no significant differences between the two groups in terms of intraoperative blood loss, intraoperative complications, or readmission rates. Conclusions: SSRS offers a feasible and promising approach for treating gynecological benign diseases. Younger and lower parity patients tend to have SSRS, compare to SPALS, and SSRS was mainly used for myomectomy and complex adnexal surgery. However, operation time and gas passing time were found to be longer in SSRS group.

  • Open Access

    Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons

    by Heon Jong Yoo, Jenny J. Hong, Young Bok Ko, Mina Lee, Youjin Kim, Hye Young Han, Yong Jung Song, Myong Cheol Lim, Sang-Yoon Park

    The goal of the study was to investigate the current clinical practices among oncologic surgeons regarding cytoreductive surgery (CRS) with intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC). From September to October 2016, an online questionnaire surveyed the oncologic surgeons by email. The questionnaire included 20 multiple-choice questions of the following: eligibility for the CRS with HIPEC procedure, perioperative staging and surgery skill, assessment of residual tumors, and method used for intraperitoneal HIPEC. The response rate was 16% (34/217). The majority of respondents (68%) worked at a university hospital. All respondents indicated that mesenteric invasion is the most crucial factor affecting treatment decision. Most surgeons (79%) used the Sugarbaker’s staging system to intraoperatively measure the extent of peritoneal invasion. The methods used to measure the extent of miliary pattern of residual tumor spread, and the amount of residual tumor after electrocauterization varied among the surgeons. Most responders (65%) used the closed system of HIPEC. Despite the fact that CRS HIPEC is the standard treatment for PSM, the clinical practices are very different according to each clinical situation. Nevertheless, mesenteric invasion was found to be the most important factor impacting the treatment decision-making by the majority of responders.